-
1
-
-
77952802391
-
Estimation and projection of lung cancer incidence and mortality in China
-
Chen W, Zhang S, Zou X,. [Estimation and projection of lung cancer incidence and mortality in China]. Zhongguo Fei Ai Za Zhi 2010; 13: 488-93.
-
(2010)
Zhongguo Fei Ai Za Zhi
, vol.13
, pp. 488-493
-
-
Chen, W.1
Zhang, S.2
Zou, X.3
-
2
-
-
0034606998
-
Lung cancer
-
DOI 10.1016/S0140-6736(00)82038-3
-
Hoffman PC, Mauer AM, Vokes EE,. Lung cancer. Lancet 2000; 355: 479-85. (Pubitemid 30085163)
-
(2000)
Lancet
, vol.355
, Issue.9202
, pp. 479-485
-
-
Hoffman, P.C.1
Mauer, A.M.2
Vokes, E.E.3
-
3
-
-
41949114548
-
Taxanes, microtubules and chemoresistant breast cancer
-
McGrogan BT, Gilmartin B, Carney DN, et al,. Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 2008; 1785: 96-132.
-
(2008)
Biochim. Biophys. Acta
, vol.1785
, pp. 96-132
-
-
McGrogan, B.T.1
Gilmartin, B.2
Carney, D.N.3
-
4
-
-
0034212385
-
Paclitaxel-induced cell death: Where the cell cycle and apoptosis come together
-
Wang TH, Wang HS, Soong YK,. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000; 88: 2619-28.
-
(2000)
Cancer
, vol.88
, pp. 2619-2628
-
-
Wang, T.H.1
Wang, H.S.2
Soong, Y.K.3
-
6
-
-
0038106665
-
Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs
-
DOI 10.1517/phgs.4.4.397.22747
-
Sakaeda T, Nakamura T, Okumura K,. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 2003; 4: 397-410. (Pubitemid 36857176)
-
(2003)
Pharmacogenomics
, vol.4
, Issue.4
, pp. 397-410
-
-
Sakaeda, T.1
Nakamura, T.2
Okumura, K.3
-
7
-
-
0020605073
-
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein
-
Kartner N, Shales M, Riordan JR, et al,. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res. 1983; 43: 4413-19. (Pubitemid 13041881)
-
(1983)
Cancer Research
, vol.43
, Issue.9
, pp. 4413-4419
-
-
Kartner, N.1
Shales, M.2
Riordan, J.R.3
Ling, V.4
-
8
-
-
33846827296
-
Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer
-
DOI 10.1111/j.1525-1438.2006.00752.x
-
Naniwa J, Kigawa J, Kanamori Y, et al,. Genetic diagnosis for chemosensitivity with drug-resistance genes in epithelial ovarian cancer. Int. J. Gynecol. Cancer 2007; 17: 76-82. (Pubitemid 46213973)
-
(2007)
International Journal of Gynecological Cancer
, vol.17
, Issue.1
, pp. 76-82
-
-
Naniwa, J.1
Kigawa, J.2
Kanamori, Y.3
Itamochi, H.4
Oishi, T.5
Shimada, M.6
Shimogai, R.7
Kawaguchi, W.8
Sato, S.9
Terakawa, N.10
-
9
-
-
0036351238
-
Multidrug resistance gene-1 is a useful predictor of paclitaxel-based chemotherapy for patients with ovarian cancer
-
DOI 10.1006/gyno.2002.6738
-
Kamazawa S, Kigawa J, Kanamori Y, et al,. Multidrug resistance gene-1 is a useful predictor of paclitaxel-based chemotherapy for patients with ovarian cancer. Gynecol. Oncol. 2002; 86: 171-6. (Pubitemid 34953500)
-
(2002)
Gynecologic Oncology
, vol.86
, Issue.2
, pp. 171-176
-
-
Kamazawa, S.1
Kigawa, J.2
Kanamori, Y.3
Itamochi, H.4
Sato, S.5
Iba, T.6
Terakawa, N.7
-
10
-
-
33846504706
-
A "silent" polymorphism in the MDR1 gene changes substrate specificity
-
DOI 10.1126/science.1135308
-
Kimchi-Sarfaty C, Oh JM, Kim IW, et al,. A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-8. (Pubitemid 46175758)
-
(2007)
Science
, vol.315
, Issue.5811
, pp. 525-528
-
-
Kimchi-Sarfaty, C.1
Oh, J.M.2
Kim, I.-W.3
Sauna, Z.E.4
Calcagno, A.M.5
Ambudkar, S.V.6
Gottesman, M.M.7
-
11
-
-
33748993393
-
Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-a-vis the NCI-60 panel
-
DOI 10.2217/14622416.7.6.843
-
Le Morvan V, Bellott R, Moisan F, et al,. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-a-vis the NCI-60 panel. Pharmacogenomics 2006; 7: 843-52. (Pubitemid 44446735)
-
(2006)
Pharmacogenomics
, vol.7
, Issue.6
, pp. 843-852
-
-
Le Morvan, V.1
Bellott, R.2
Moisan, F.3
Mathoulin-Pelissier, S.4
Bonnet, J.5
Robert, J.6
-
12
-
-
0024362996
-
185 with an altered pattern of multidrug resistance
-
Kioka N, Tsubota J, Kakehi Y, et al,. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun. 1989; 162: 224-31. (Pubitemid 19185850)
-
(1989)
Biochemical and Biophysical Research Communications
, vol.162
, Issue.1
, pp. 224-231
-
-
Kioka, N.1
Tsubota, J.2
Kakehi, Y.3
Komano, T.4
Gottesman, M.M.5
Pastan, I.6
Ueda, K.7
-
13
-
-
52049100135
-
Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers
-
Xu P, Jiang ZP, Zhang BK, et al,. Impact of MDR1 haplotypes derived from C1236T, G2677T/A and C3435T on the pharmacokinetics of single-dose oral digoxin in healthy Chinese volunteers. Pharmacology 2008; 82: 221-7.
-
(2008)
Pharmacology
, vol.82
, pp. 221-227
-
-
Xu, P.1
Jiang, Z.P.2
Zhang, B.K.3
-
14
-
-
62749204334
-
G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern
-
Kwon WS, Rha SY, Jeung HC, et al,. G-T haplotype (2677G>T/A and 3435C>T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern. Cancer Lett. 2009; 277: 155-63.
-
(2009)
Cancer Lett.
, vol.277
, pp. 155-163
-
-
Kwon, W.S.1
Rha, S.Y.2
Jeung, H.C.3
-
15
-
-
60549112572
-
Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients
-
Chang H, Rha SY, Jeung HC, et al,. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Ann. Oncol. 2009; 20: 272-7.
-
(2009)
Ann. Oncol.
, vol.20
, pp. 272-277
-
-
Chang, H.1
Rha, S.Y.2
Jeung, H.C.3
-
16
-
-
32944468151
-
MDR-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy
-
DOI 10.1158/1078-0432.CCR-05-0950
-
Green H, Soderkvist P, Rosenberg P, et al,. MDR-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy. Clin. Cancer Res. 2006; 12: 854-9. (Pubitemid 43259868)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.3
, pp. 854-859
-
-
Green, H.1
Soderkvist, P.2
Rosenberg, P.3
Horvath, G.4
Peterson, C.5
-
17
-
-
0034997034
-
Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene
-
Tanabe M, Ieiri I, Nagata N, et al,. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther. 2001; 297: 1137-43. (Pubitemid 32472514)
-
(2001)
Journal of Pharmacology and Experimental Therapeutics
, vol.297
, Issue.3
, pp. 1137-1143
-
-
Tanabe, M.1
Ieiri, I.2
Nagata, N.3
Inoue, K.4
Ito, S.5
Kanamori, Y.6
Takahashi, M.7
Kurata, Y.8
Kigawa, J.9
Higuchi, S.10
Terakawa, N.11
Otsubo, K.12
-
18
-
-
40549099027
-
Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration
-
DOI 10.1097/FPC.0b013e3282f70458, PII 0121301120080400000003
-
Aarnoudse AJ, Dieleman JP, Visser LE, et al,. Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration. Pharmacogenet. Genomics 2008; 18: 299-305. (Pubitemid 351367523)
-
(2008)
Pharmacogenetics and Genomics
, vol.18
, Issue.4
, pp. 299-305
-
-
Aarnoudse, A.-J.L.H.J.1
Dieleman, J.P.2
Visser, L.E.3
Arp, P.P.4
Van Der Heiden, I.P.5
Van Schaik, R.H.N.6
Molokhia, M.7
Hofman, A.8
Uitterlinden, A.G.9
Stricker, B.H.Ch.10
-
19
-
-
0036904332
-
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males
-
DOI 10.1046/j.1365-2125.2002.01691.x
-
Gerloff T, Schaefer M, Johne A, et al,. MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white males. Br. J. Clin. Pharmacol. 2002; 54: 610-16. (Pubitemid 36002588)
-
(2002)
British Journal of Clinical Pharmacology
, vol.54
, Issue.6
, pp. 610-616
-
-
Gerloff, T.1
Schaefer, M.2
Johne, A.3
Oselin, K.4
Meisel, C.5
Cascorbi, I.6
Roots, I.7
-
20
-
-
0036667953
-
C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation
-
DOI 10.1097/00008571-200208000-00005
-
Goto M, Masuda S, Saito H, et al,. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation. Pharmacogenetics 2002; 12: 451-7. (Pubitemid 34913527)
-
(2002)
Pharmacogenetics
, vol.12
, Issue.6
, pp. 451-457
-
-
Goto, M.1
Masuda, S.2
Saito, H.3
Uemoto, S.4
Kiuchi, T.5
Tanaka, K.6
Inui, K.-I.7
-
21
-
-
58149263115
-
No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects
-
Guo X, Chen XP, Cheng ZN, et al,. No effect of MDR1 C3435T polymorphism on oral pharmacokinetics of telmisartan in 19 healthy Chinese male subjects. Clin. Chem. Lab. Med. 2009; 47: 38-43.
-
(2009)
Clin. Chem. Lab. Med.
, vol.47
, pp. 38-43
-
-
Guo, X.1
Chen, X.P.2
Cheng, Z.N.3
-
22
-
-
84965822602
-
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
-
Alley MC, Scudiero DA, Monks A, et al,. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988; 48: 589-601. (Pubitemid 18056527)
-
(1988)
Cancer Research
, vol.48
, Issue.3
, pp. 589-601
-
-
Alley, M.C.1
Scudiero, D.A.2
Monks, A.3
Hursey Czerwinski, M.L.M.J.4
Fine, D.L.5
Abbott, B.J.6
Mayo, J.G.7
Shoemaker, R.H.8
Boyd, M.R.9
-
23
-
-
34447573875
-
Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: A phase III trial in non-small-cell lung cancer
-
DOI 10.1200/JCO.2006.09.7915
-
Cobo M, Isla D, Massuti B, et al,. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer. J. Clin. Oncol. 2007; 25: 2747-54. (Pubitemid 47123183)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.19
, pp. 2747-2754
-
-
Cobo, M.1
Isla, D.2
Massuti, B.3
Montes, A.4
Sanchez, J.M.5
Provencio, M.6
Vinolas, N.7
Paz-Ares, L.8
Lopez-Vivanco, G.9
Munoz, M.A.10
Felip, E.11
Alberola, V.12
Camps, C.13
Domine, M.14
Sanchez, J.J.15
Sanchez-Ronco, M.16
Danenberg, K.17
Taron, M.18
Gandara, D.19
Rosell, R.20
more..
-
24
-
-
34447338821
-
Immunohistochemichal expression of biomarkers: A comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer
-
DOI 10.1093/annonc/mdm072
-
Taillade L, Penault-Llorca F, Boulet T, et al,. Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer. Ann. Oncol. 2007; 18: 1043-50. (Pubitemid 47050496)
-
(2007)
Annals of Oncology
, vol.18
, Issue.6
, pp. 1043-1050
-
-
Taillade, L.1
Penault-Llorca, F.2
Boulet, T.3
Fouret, P.4
Michiels, S.5
Taranchon, E.6
Mountzios, G.7
Validire, P.8
Domont, J.9
Girard, P.10
Grunenwald, D.11
Le Chevalier, T.12
Soria, J.-C.13
-
25
-
-
0141456467
-
HER-2/Neu alterations in non-small cell lung cancer: A comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry
-
Pellegrini C, Falleni M, Marchetti A, et al,. HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry. Clin. Cancer Res. 2003; 9: 3645-52. (Pubitemid 37169230)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.10
, pp. 3645-3652
-
-
Pellegrini, C.1
Falleni, M.2
Marchetti, A.3
Cassani, B.4
Miozzo, M.5
Buttitta, F.6
Roncalli, M.7
Coggi, G.8
Bosari, S.9
-
26
-
-
21444459236
-
DNA repair gene polymorphisms affect cytotoxicity in the National Cancer Institute Human Tumor Cell Line Screening Panel
-
DOI 10.1080/13547500500138732
-
Yarosh DB, Pena A, Brown DA,. DNA repair gene polymorphisms affect cytotoxicity in the National Cancer Institute Human Tumour Cell Line Screening Panel. Biomarkers 2005; 10: 188-202. (Pubitemid 40916675)
-
(2005)
Biomarkers
, vol.10
, Issue.2-3
, pp. 188-202
-
-
Yarosh, D.B.1
Pena, A.2
Brown, D.A.3
-
27
-
-
33847611097
-
Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel
-
DOI 10.1016/j.ejca.2006.12.012, PII S0959804907000135
-
Nief N, Le Morvan V, Robert J,. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel. Eur. J. Cancer 2007; 43: 955-62. (Pubitemid 46366695)
-
(2007)
European Journal of Cancer
, vol.43
, Issue.5
, pp. 955-962
-
-
Nief, N.1
Morvan, V.L.2
Robert, J.3
-
28
-
-
73449118589
-
Pharmacogenomic discovery using cell-based models
-
Welsh M, Mangravite L, Medina MW, et al,. Pharmacogenomic discovery using cell-based models. Pharmacol. Rev. 2009; 61: 413-29.
-
(2009)
Pharmacol. Rev.
, vol.61
, pp. 413-429
-
-
Welsh, M.1
Mangravite, L.2
Medina, M.W.3
-
29
-
-
1642523162
-
Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance
-
DOI 10.1016/j.clpt.2003.09.012
-
Marzolini C, Paus E, Buclin T, et al,. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. 2004; 75: 13-33. (Pubitemid 38130115)
-
(2004)
Clinical Pharmacology and Therapeutics
, vol.75
, Issue.1
, pp. 13-33
-
-
Marzolini, C.1
Paus, E.2
Buclin, T.3
Kim, R.B.4
-
30
-
-
47349110179
-
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
-
Zhou SF,. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008; 38: 802-32.
-
(2008)
Xenobiotica
, vol.38
, pp. 802-832
-
-
Zhou, S.F.1
-
31
-
-
0037282898
-
Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression
-
DOI 10.1159/000068411
-
Yeh JJ, Hsu WH, Wang JJ, et al,. Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression. Respiration 2003; 70: 32-5. (Pubitemid 36216644)
-
(2003)
Respiration
, vol.70
, Issue.1
, pp. 32-35
-
-
Yeh, J.J.1
Hsu, W.H.2
Wang, J.J.3
Ho, S.T.4
Kao, A.5
-
32
-
-
0036693051
-
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein
-
DOI 10.1067/mcp.2002.126177
-
Kurata Y, Ieiri I, Kimura M, et al,. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin. Pharmacol. Ther. 2002; 72: 209-19. (Pubitemid 35034499)
-
(2002)
Clinical Pharmacology and Therapeutics
, vol.72
, Issue.2
, pp. 209-219
-
-
Kurata, Y.1
Ieiri, I.2
Kimura, M.3
Morita, T.4
Irie, S.5
Urae, A.6
Ohdo, S.7
Ohtani, H.8
Sawada, Y.9
Higuchi, S.10
Otsubo, K.11
-
33
-
-
3042772026
-
Identification of functionally variant MDR1 alleles among European Americans and African Americans
-
DOI 10.1067/mcp.2001.117412
-
Kim RB, Leake BF, Choo EF, et al,. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther. 2001; 70: 189-99. (Pubitemid 32777772)
-
(2001)
Clinical Pharmacology and Therapeutics
, vol.70
, Issue.2
, pp. 189-199
-
-
Kim, R.B.1
Leake, B.F.2
Choo, E.F.3
Dresser, G.K.4
Kubba, S.V.5
Schwarz, U.I.6
Taylor, A.7
Xie, H.-G.8
McKinsey, J.9
Zhou, S.10
Lan, L.-B.11
Schuetz, J.D.12
Schuetz, E.G.13
Wilkinson, G.R.14
-
34
-
-
33749989048
-
MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells
-
DOI 10.1002/jps.20717
-
Salama NN, Yang Z, Bui T, et al,. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. J. Pharm. Sci. 2006; 95: 2293-308. (Pubitemid 44568538)
-
(2006)
Journal of Pharmaceutical Sciences
, vol.95
, Issue.10
, pp. 2293-2308
-
-
Salama, N.N.1
Yang, Z.2
Bui, T.3
Ho, R.J.Y.4
-
35
-
-
0037131893
-
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans
-
DOI 10.1016/S0169-409X(02)00064-9, PII S0169409X02000649
-
Fromm MF,. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans. Adv. Drug Deliv. Rev. 2002; 54: 1295-310. (Pubitemid 35284254)
-
(2002)
Advanced Drug Delivery Reviews
, vol.54
, Issue.10
, pp. 1295-1310
-
-
Fromm, M.F.1
|